Thermo Fisher Scientific has announced the establishment of a new Biomarker Translational Centre to be based in Cambridge, Massachusetts.The centre is to accelerate mass spectrometry-based biomarker discovery research and its translation into the development of routing clinical assays for commercialisation. It will combine advanced expertise from across the company, including its B.R.A.H.M.S product line and Biomarkers Research Initiatives in Mass Spectrometry (BRIMS) Centre.
展开▼
